Brenig Therapeutics initiates first-in-human study of BT-409, a brain-selective NLRP3 inhibitor: Boston, Massachusetts Monday, January 19, 2026, 18:00 Hrs [IST] Brenig Therapeutic ...

Overview On January 14, NSFOCUS CERT detected that Microsoft released the January Security Update patch, which fixed 112 security issues involving widely used products such as Windows, Microsoft ...

Adyton Resources Corporation (TSXV: ADY) (“Adyton” or the “Company”) is pleased to announce an updated NI 43-101 Mineral ...

Trainer Cherie DeVaux has a pair of live horses in both tomorrow’s Road to the Derby Stakes for 3-year-olds, the ...

In the child welfare system, the threshold at which a drug test is considered positive varies widely from one jurisdiction to ...

Meta is pulling the plug on its business-focused VR hardware and services to focus on artificial intelligence, but its consumer-focused VR business will continue. The company confirmed it will be ...

"The first half of 2026 will likely deliver uncomfortably slow growth in the labour market, with unemployment peaking at 4.5% ...

CELEBRITIES used to credit their eternally youthful glow to green juice and eight hours’ sleep a night – a mere whisper of a ...

Richard White, Founder & CEO of Fathom, is a repeat founder and product-focused entrepreneur best known for turning personal ...

AB-1009 is an investigational gene therapy that has not been approved by any regulatory authority, and its efficacy and safety have not been established or fully evaluated. For more information, ...

There is an undeniable connection between a strong immune system and nutrition. Learn why what you eat matters and other ways to boost your immune system.